Increased bleeding risk with phosphodiesterase‐5 inhibitors after left ventricular assist device implantation

AIMS: Therapy with phosphodiesterase‐5 inhibitors (PDE5Is) after left ventricular assist device (LVAD) implantation has been associated with lower mortality and device thrombosis but increased risk for post‐operative and gastrointestinal bleeding. We aimed to evaluate the impact of long‐term PDE5Is...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:ESC Heart Fail
Autors principals: Jakstaite, Aiste‐Monika, Luedike, Peter, Schmack, Bastian, Pizanis, Nikolaus, Riebisch, Matthias, Weymann, Alexander, Kamler, Markus, Ruhparwar, Arjang, Rassaf, Tienush, Papathanasiou, Maria
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2021
Matèries:
Original Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8318463/
https://ncbi.nlm.nih.gov/pubmed/33821578
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13322
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars